Equity
€289,759 ▼ 7.0%
RADIM paid out €113,143 in dividends. That is 124% of the 2025 profit.
RADIM
Lifetime
20 annual accounts with figures on one time axis, 34 filings since 1992peak €407,093 (2022)
€191,879▼ 7.4%
lowest -€9,372 (2015)
€91,379▼ 10.5%
peak €311,522 (2024)
€289,759▼ 7.0%
€169,640▲ 80.6%
peak 1.1 FTE (2008)
1 FTE
Board2 names since 2021
2 directorsMEDRIX and 1 other
Owners
50%MEDRIX
Documentsfilings and deeds
18-08-202618 days late
2025abbreviated format
Permanent representative: Pierre Trefois 04-09Resignation: PierreTrefois (director) 04-06Dividend €113,143Debts from €93,950 to €169,640Cash from €324,745 to €115,932
Key points
from the 2025 annual accountsChecked score
93
Excellent
Financially stronger than 44% of micro companies in human health (NACE 86)
Probability in this band: under 0.55%
Bankruptcy probability within 12 months
< 0.1% Very low
0%0.5%1.5%4%10%≥ 25%
The dashed line is the sector median: < 0.1% across 24,185 companies (NACE 86, micro).
Fewer than 1 in 1,000 comparable companies go bankrupt within 12 months (an estimate).
Last 24 months
12-2024: 0.1%
01-2025: 0.1%● unchanged vs 12-2024
02-2025: 0.1%● unchanged vs 01-2025
03-2025: 0.1%● unchanged vs 02-2025
04-2025: 0.1%● unchanged vs 03-2025
05-2025: < 0.1%▼ -0.1 percentage points vs 04-2025
06-2025: 0.1%▲ +0.1 percentage points vs 05-2025
07-2025: 0.1%● unchanged vs 06-2025
08-2025: 0.1%● unchanged vs 07-2025highest value
09-2025: < 0.1%▼ -0.1 percentage points vs 08-2025
10-2025: < 0.1%● unchanged vs 09-2025
11-2025: < 0.1%● unchanged vs 10-2025
12-2025: < 0.1%● unchanged vs 11-2025
01-2026: < 0.1%● unchanged vs 12-2025
02-2026: < 0.1%● unchanged vs 01-2026
03-2026: < 0.1%● unchanged vs 02-2026
04-2026: < 0.1%● unchanged vs 03-2026
05-2026: < 0.1%● unchanged vs 04-2026
06-2026: < 0.1%● unchanged vs 05-2026lowest value
07-2026: < 0.1%● unchanged vs 06-2026
08-2026: < 0.1%● unchanged vs 07-2026
09-2026: < 0.1%● unchanged vs 08-2026
10-2026: < 0.1%● unchanged vs 09-2026
11-2026: < 0.1%● unchanged vs 10-2026
Financial strengthStrong
Score breakdown
lowers risk
Sector: Human health activities (NACE 86)
Liquidity: current ratio 2.60, cash €115,932, halved
Founded in 1992
Size: 1 FTE, total assets €459,399
Calculation
The band follows from the bankruptcy probability. 10 more points roughly halve it.
| 75-100 | Excellent | under 0.55% |
| 60-74 | Healthy | 0.55% to 1.5% |
| 45-59 | Fair | 1.5% to 4.2% |
| 25-44 | Weak | 4.2% to 15.0% |
| 0-24 | Critical | over 15.0% |
Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 86, micro). It does better than 51% of them on solvency, 44% on liquidity, 52% on profitability and 28% on growth.
The bankruptcy probability was computed on 09-11-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.
The probability rests on the annual accounts with balance sheet date 31-12-2025.
Of the companies with a bankruptcy probability in the very low class on 30-06-2025, 0.1% went bankrupt within twelve months.
Some facts cap the score, however low the probability. With negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late, the score is Fair at most (59). With two missing filings, it is Weak at most (44). During a judicial reorganisation or at the company's end (bankruptcy, dissolution, liquidation), it is Critical at most (24).
Comparable companies, two years later
In July 2024, 31,368 companies had the same profile as RADIM has now. Each dot stands for 79 companies, two years later.
93.5%
were still trading
5.9%
stopped another way
0.5%
went bankrupt
Another 0.1% stopped without a precise date, possibly only after those two years.
That fits the bankruptcy probability of RADIM itself: < 0.1% within 12 months.
Test of the method
The method was tested on the 497,447 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.
| Group | Expected | Actual |
|---|---|---|
| 1 | 0.2% | 0.2% |
| 2 | 0.3% | 0.5% |
| 3 | 0.5% | 0.6% |
| 4 | 0.7% | 0.8% |
| 5 | 0.9% | 0.9% |
| 6 | 1.3% | 1.5% |
| 7 | 1.6% | 1.8% |
| 8 | 1.8% | 1.8% |
| 9 | 3.0% | 3.1% |
| 10 | 5.6% | 6.2% |
A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.
This is an observation about 31,368 companies, not a prediction for RADIM. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.
Credit verdict
Credit of up to €25,000 on 30-day terms is acceptable
Liquidity is ample, with a current ratio of 2.6 (3.86 in 2024), above the usual 1.5. Short-term debt is 36.8% and cash 25.2% of total assets. 36.9% of the assets are financed with debt and provisions.
Credit check for an amount and term of your choice
Show the recommended maximum and see how the verdict changes with amount, term and advance.
The scores and ratios are Checked's own calculations, not a credit decision.
Signals
Five signals.
lowers riskraises risk
raises risk · 2025 accounts filed 18 days late
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 18-08-2026, 18 days later. Nearly half (47%) of Belgian companies file late; of those that file 1 to 90 days late, 2.0% are now bankrupt, dissolved or in another special legal status, against 1.66% of all filers. A delay like this does not count in the score.
NBB · 10 filingsDeviation from the deadline
2025
18 days late
2024
29 days late
2023
64 days late
2022
144 days late
2021
31 days late
2020
31 days late
2019
31 days late
← before the deadline
after the deadline →
tick = median of all Belgian filingsring = median in the sector
The company filed its last 7 accounts on average 50 days after the deadline. In the sector (NACE 86), the median for financial year 2024 was 7 days before the deadline, and 36% of those companies filed late.
Searched, nothing found (2)
neutral · Next filing not due yet
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today. The company usually files around 31 August (4 of the last 5 accounts filed within 34 days either side of that date).
Companies Code · seven monthsWhere today falls in the filing period
10-11-2026 today31-12-2026 year end31-07-2027 deadline
Board and ownership
- MEDRIX 50%score 95equity €378,281 (2025) · 2025 annual accounts of MEDRIX
- Pierre Trefoisannual accounts 2025
Recent changes
Registered in the Peppol Directory
Reachable for e-invoices through 0208:0447170493
Permanent representative: Pierre Trefois
Appointment: MEDRIX (director) · General meeting of 15-05-2025 · Gazette deed
Resignation: PierreTrefois (director)
Permanent representative: PierreTrefois · Director discharge: PierreTrefois · General meeting of 15-05-2025 · Gazette deed
Company renamed from Centre de Radiologie et d’Imagerie de la Clinique Saint-Anne to RADIM
Change of role: Pierre Trefois, from statutory manager to director · “En assurant la gestion d’un centre médical ou d’un cabinet médical, en ce compris l’acquisition, la location…” (deed in French) · Legal-form conversion: from private limited company (pre-2019) to private limited company · General meeting of 09-06-2023 · Gazette deed
Comparable companies
same main activity, similar in size and age| Company | ||||
|---|---|---|---|---|
| RADIM Anderlecht | €459,399 | €191,879 | 63.1% | 1 |
| LabCare Plus Ghent | €398,262 | €205,721 | 82.1% | 1.2 |
| MEDISCH KABINET DR. DHADAMUS A. Haacht | €677,077 | €178,788 | 90.0% | 0.5 |
| Coopération Hospitalière de l'Arrondissement de Mons-Borinage Deuxième Mons | €634,101 | €140,397 | 5.9% | 0.9 |
| Medische Beeldvorming Dendermonde Dendermonde | €426,876 | €207,522 | 80.3% | 1.9 |
| Labo Service Belgium Kontich | €715,088 | €190,333 | 53.4% | 2 |
| DR. HILDE DURANT Lochristi | €468,680 | €316,075 | 55.4% | 2.1 |
These companies have the same main activity as RADIM: medical imaging and medical laboratories (NACE 86910). They are comparable in size and age: total assets between €398,000 and €715,000, founded between 1982 and 2003.
Official details
Source: KBO- Status
- Active since 23-04-1992Normal situation
- Activity
- Medical imaging and medical laboratoriesNACE 86910
- Joint committee
- 330.04Health institutions and services · annual accounts 2025
- Establishment unit
- 2.230.281.3091070 Anderlecht, since 23-04-1992
- Financial year end
- 31 December
- Peppol
- Reachable since 07-05-2026
Annual accounts 2025
- ≈ €370,000estimated
- €459,399▲ 13.3%
- Employeeson 31-12-2025
- 1=
- Filing
- Filed on 18-08-2026
Insights on RADIM
RADIM files the abbreviated format. That format states no turnover. The gross margin rose from €133,913 in 2006 to €191,879 in 2025.
The balance sheet grew most in 2019 through fixed assets.
Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.
Key facts about RADIM
- What is the company number of RADIM?
- The company number of RADIM is 0447.170.493. The VAT number is the same number with BE in front: BE 0447.170.493.
- Where is RADIM based?
- The registered office is at Luitenant Liedelstraat 14, 1070 Anderlecht.Company details
- What does RADIM do?
- According to the KBO register, the main activity is medical imaging and medical laboratories (NACE 86910).
- What is the legal form of RADIM?
- RADIM is a private limited company (BV).
- When was RADIM founded?
- RADIM was founded on 23-04-1992.
- Is RADIM still active?
- Yes, RADIM is an active enterprise in the KBO register.
- How many employees does RADIM have?
- RADIM had an average of 1 full-time equivalents in financial year 2025, according to the filed annual accounts.Financials
- Which joint committee does RADIM fall under?
- In its 2025 annual accounts, RADIM states joint committee 330.04 (Health institutions and services).
- What is the turnover of RADIM?
- The turnover in financial year 2025 is ≈ €370,000. This figure is estimated from the gross margin of €191,879 and 44 comparable companies (NACE 86). It probably lies between €320,000 and €530,000.
- Is RADIM profitable?
- In financial year 2025, RADIM made a profit of €91,379.
- Where can I find the annual accounts of RADIM?
- RADIM filed 34 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
- When are the next annual accounts of RADIM due?
- RADIM must file the annual accounts for financial year 2026 by 31-07-2027.Timeline
Next steps
Work out how much credit to give this customer and on what payment terms.Credit check Check what to know before you do business with this company.Supplier due diligence Check whether you can accept this company as a client under the anti-money-laundering law.AML client file Check which of your other customers you can e-invoice via Peppol.Peppol check Compare this company with its sector.Sector benchmark See what changed in the latest annual accounts.What changed
See how customers, suppliers and banks see your own company and what to improve first.